K. Rossen et al., BCL-2 OVEREXPRESSION IN BASALOID PROLIFERATIONS OVERLYING DERMATOFIBROMAS AND BASAL-CELL CARCINOMAS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(1), 1997, pp. 35-40
Basaloid proliferations overlying dermatofibromas resembling superfici
al basal cell carcinomas have been interpreted both as reactive/regres
sive and frankly malignant. Basal cell carcinoma is a slow-growing tum
our, which so far has been regarded as an actively proliferating lesio
n with a high apoptotic activity. We examined immunohistochemically 6
dermatofibromas with overlying simple hyperplasia, 12 dermatofibromas
with overlying basaloid proliferations, and 24 basal cell carcinomas f
or expression of Ki-67 protein and bcl-2 protein. The Ki-67 labelling
index represents an estimate of proliferative activity. Eel-2 protein
suppresses apoptosis. The Ki-67 labelling indexes of basaloid prolifer
ations, basal cell carcinomas, and normal epidermis were similar (11-1
5%, p<0.05, Mann-Whitney test). Eel-2 protein was expressed in all cel
ls of basaloid proliferations, similar to the expression pattern in ba
sal cell carcinomas. We suggest that basaloid proliferations overlying
dermatofibromas might have achieved a phenotype that equals an early
stage of BCC carcinogenesis.